CDC published ACIP recommendations for use of cholera vaccine
On May 12, 2017, the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices…
-
-
Siteman Cancer Center met the standards of the American Society for Radiation Oncology Accreditation Program for Excellence
On May 10, 2017, the Siteman Cancer Center met the standards of the American Society for Radiation Oncology…
-
University of Pennsylvania announced $1.5 billion Hospital Pavilion
On May 3, 2017, the University of Pennsylvania announced to build a $1.5 billion new hospital on Penn…
-
Screwworm eradicated in Florida, again
On April 26, 2017, the U.S. Department of Agriculture’s (USDA) announced that the New World screwworm (NWS) had…
-
The University of Virginia Cancer Center received $15 million Renewal grant
On Apr. 26, 2017, the University of Virginia Cancer Center was honored as one of just 69 National…
-
HitGen announced drug discovery collaboration with Scripps Research Institute and Calibr
On Apr. 24, 2017, HitGen Ltd., a privately held biotech company focused on technology for effective and efficient small…
-
Biotechnology | Disease | Infectious Disease | Influenza | Non-Profit Research | Therapeutics | Vaccine
CDC updated guidelines for use of non-pharmaceutical measures to help prevent spread of pandemic influenza
On Apr. 21, 2017, the U.S. Centers for Disease Control and Prevention (CDC) published updated guidelines for use…
-
Biotechnology | Diagnostics | Neurology | Therapeutics | WHO
Some 300 million people suffer from depression worldwide
On Mar. 31, 2017, more than 300 million people are now living with depression, which is the leading…
-
Bezos family donated $35 million to Fred Hutch
On Mar. 30, 2017, the Fred Hutchinson Cancer Research Center announced that the Bezos family had donated $35…
-
Genentech drug Ocrevus (ocrelizumab) was approved
On Mar. 28, 2017, Genentech drug Ocrevus (ocrelizumab) was approved by the U.S. Food and Drug Administration (FDA)…
-
University of Alberta researchers announced they had discovered the protein Rab32 in the brains of MS patients.
On Mar. 25, 2017, University of Alberta researchers announced they had discovered the protein Rab32 in the brains…
-
the Siteman Cancer Network Center was launched
On Mar. 3, 2017, Siteman Cancer Center launched the Siteman Cancer Network to improve the health of individuals…
-
Cleveland Clinic opened new cancer Center
On Feb. 16, 2017, the new Cleveland Clinic Taussig Cancer Center began welcoming patients. The 377,000-square-foot facility, estimated…
-
CDC published the 2017 US recommended immunization schedules for 0 through 18 years
On Feb. 10, 2017, the Advisory Committee on Immunization Practices (ACIP) approved the Recommended Immunization Schedule for Children…
-
CDC published the 2017 U.S. recommended adult immunization schedule
On Feb. 10, 2017, the U.S. Centers for Disease Control and Prevention (CDC) published the 2017 U.S. recommended…
-
The Bill & Melinda Gates Foundation pledged $279 million to University of Washington’s Institute for Health Metrics and Evaluation
On Jan. 25, 2017, the Bill & Melinda Gates Foundation pledged $279 million to the University of Washington’s…
-
Scripps Research Institute scientists created first stable semisynthetic organism
On Jan. 23, 2017, scientists at The Scripps Research Institute (TSRI) announced the development of the first stable…
-
PharmAthene and Altimmune announced merger to create immunotherapeutics company targeting infectious diseases
On Jan. 19, 2017, PharmAthene and Altimmune, a privately-held immunotherapeutics company targeting infectious diseases, announced an agreement for…
-
Canada Foundation awarded $6 million for Innovation Metabolomics Innovation Centre at the University of Alberta
On Jan. 9, 2017, the Canada Foundation for Innovation (CFI) awarded $6 million for Canada’s national metabolomics laboratory,…
-
Jackson Lab Wins fight over CRISPR patent
On Jan. 3, 2017, the Jackson Laboratory announced it had obtained CRISPR licenses from the University of California,…
-
First drug approved by the FDA for treatment of canine lymphoma
On Jan. 3, 2017, the U.S. Food and Drug Administration’s Center for Veterinary Medicine (CVM) announced the conditional…
-
BioXcel therapeutics was founded
In 2017, BioXcel Therapeutics was founded in New Haven, Connecticut as a clinical-stage biopharmaceutical company that utilizes novel…
-
SpringWorks Therapeutics was founded
In 2017, SpringWorks Therapeutics was founded in Stamford, Connecticut, as a clinical-stage biopharmaceutical company that applies a precision…
-
The Vanderbilt Microbiome Initiative was founded
In 2017, the Vanderbilt Microbiome Initiative (VMI) at Vanderbilt University was established bringing together an unprecedented group of…
-
The Asian longhorned tick found in Virginia
In 2017, Virginia Tech veterinary pathologist Kevin Lahmers identified the Asian longhorned tick as the source of seven…
-
Genomic sequencing illuminated Shigella outbreaks in California
On Dec. 23, 2016, researchers at University of California (UC) Davis and California Department of Public Health (CDPH)…
-
Biotechnology | Disease | NIH | Therapeutics | Vaccine
Medigen Vaccines Biologics teamed with U.S. CDC to develop VLP vaccine for Dengue disease
On Dec. 14, 2016, Medigen Vaccine Biologics (MVC) amended an existing agreement with the National Institutes of Health…
-
Bristol-Myers Squibb announced closure of Seattle’s ZymoGenetics operation
On Dec. 13, 2016, Bristol-Myers Squibb announced that it would not renew its lease at the Lake Union…
-
Biotechnology | Diagnostics | Disease | Genomics | Medicine | Non-Profit Research | Oncology | Pharmaceutical | Radiology | Therapeutics
Celgene, Dana-Farber, and University of Arkansas established the Myeloma Genome Project
On Dec. 3, 2016, Celgene, Dana-Farber Cancer Institute and the University of Arkansas for Medical Sciences announced the…
-
Selexys Pharmaceuticals Corp was acquired by Novartis
On Nov. 21, 2016, Novartis announced it had acquired Selexys Pharmaceuticals Corp, a Oklahoma City-based company that specialized…
